PrimeraDx Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Employees
-
16
- Latest Deal Type
-
M&A
PrimeraDx General Information
Description
Developer of multiplex-based assays intended for infectious disease detection. The company provides scalable target amplification routine technology, which is a method for simultaneous quantitative measurement of multiple target nucleic acids, and it also offers a multiplexed assay providing quantitative and simultaneous measurement of viruses, fungal panels for mycology testing, enabling academic research centers, reference laboratories and bio-pharmaceutical companies for simultaneous detection and quantification of disparate target types, such as mRNA, miRNA, SNPs and DNA.
Contact Information
Website
www.primeradx.comCorporate Office
- 171 Forbes Boulevard
- Suite 1000
- Mansfield, MA 02048
- United States
Corporate Office
- 171 Forbes Boulevard
- Suite 1000
- Mansfield, MA 02048
- United States
PrimeraDx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 01-Mar-2014 | Completed | Profitable | |||
| 5. Grant | 26-Sep-2012 | Completed | Profitable | |||
| 4. Later Stage VC (Series C) | 21-Sep-2009 | Completed | Profitable | |||
| 3. Early Stage VC (Series B) | 07-Jan-2008 | Completed | Profitable | |||
| 2. Early Stage VC (Series A2) | 21-Nov-2007 | $2.5M | $13.5M | Completed | Profitable | |
| 1. Early Stage VC (Series A) | 11-Jul-2005 | $11M | $11M | Completed | Startup |
PrimeraDx Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series C | ||||||||
| Series B1 | ||||||||
| Series A1 | 11,090,986 | $0.001000 | 5% | $1 | $0.31 | 0x | $1 | 4.62% |
| Series A | 3,257,214 | $0.001000 | 5% | $1 | $0.31 | 0x | $1 | 1.36% |
PrimeraDx Comparisons
Industry
Financing
Details
PrimeraDx Competitors (6)
One of PrimeraDx’s 6 competitors is Onyx, a Venture Capital-Backed company based in Berkeley, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Onyx | Venture Capital-Backed | Berkeley, CA | ||||
| Biocept | Formerly VC-backed | San Diego, CA | ||||
| ACGT | Corporation | Wheeling, IL | ||||
| Charles River Laboratories International | Formerly PE-Backed | Wilmington, MA | ||||
| Taconic Biosciences | Private Equity-Backed | Rensselaer, NY |
PrimeraDx Patents
PrimeraDx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2003291144-A1 | Sampling method and apparatus for amplification reaction analysis | Inactive | 21-Nov-2002 | ||
| CA-2509769-A1 | Sampling method and apparatus for amplification reaction analysis | Inactive | 21-Nov-2002 | ||
| EP-1563097-A2 | Sampling method and apparatus for amplification reaction analysis | Inactive | 21-Nov-2002 | ||
| EP-1563097-A4 | Sampling method and apparatus for amplification reaction analysis | Inactive | 21-Nov-2002 | ||
| WO-2004048528-A2 | Sampling method and apparatus for amplification reaction analysis | Inactive | 21-Nov-2002 | B01L7/52 |
PrimeraDx Signals
PrimeraDx Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Abingworth | Venture Capital | Minority | ||
| Axiom Venture Partners | Venture Capital | Minority | ||
| Burrill & Co | Merchant Banking Firm | Minority | ||
| CHL Medical Partners | Venture Capital | Minority | ||
| InterWest Partners | Venture Capital | Minority |
PrimeraDx FAQs
-
When was PrimeraDx founded?
PrimeraDx was founded in 2004.
-
Where is PrimeraDx headquartered?
PrimeraDx is headquartered in Mansfield, MA.
-
What is the size of PrimeraDx?
PrimeraDx has 16 total employees.
-
What industry is PrimeraDx in?
PrimeraDx’s primary industry is Discovery Tools (Healthcare).
-
Is PrimeraDx a private or public company?
PrimeraDx is a Private company.
-
What is PrimeraDx’s current revenue?
The current revenue for PrimeraDx is .
-
How much funding has PrimeraDx raised over time?
PrimeraDx has raised $53.9M.
-
Who are PrimeraDx’s investors?
Abingworth, Axiom Venture Partners, Burrill & Co, CHL Medical Partners, and InterWest Partners are 5 of 9 investors who have invested in PrimeraDx.
-
Who are PrimeraDx’s competitors?
Onyx, Biocept, ACGT, Charles River Laboratories International, and Taconic Biosciences are some of the 6 competitors of PrimeraDx.
-
When was PrimeraDx acquired?
PrimeraDx was acquired on 01-Mar-2014.
-
Who acquired PrimeraDx?
PrimeraDx was acquired by Qiagen.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process